These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 33126827)

  • 1. Hypermethylation and global remodelling of DNA methylation is associated with acquired cisplatin resistance in testicular germ cell tumours.
    Fazal Z; Singh R; Fang F; Bikorimana E; Baldwin H; Corbet A; Tomlin M; Yerby C; Adra N; Albany C; Lee S; Freemantle SJ; Nephew KP; Christensen BC; Spinella MJ
    Epigenetics; 2021 Oct; 16(10):1071-1084. PubMed ID: 33126827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential methylation EPIC analysis discloses cisplatin-resistance related hypermethylation and tumor-specific heterogeneity within matched primary and metastatic testicular germ cell tumor patient tissue samples.
    Lobo J; Constâncio V; Leite-Silva P; Guimarães R; Cantante M; Braga I; Maurício J; Looijenga LHJ; Henrique R; Jerónimo C
    Clin Epigenetics; 2021 Apr; 13(1):70. PubMed ID: 33823933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reciprocal epigenetic remodeling controls testicular cancer hypersensitivity to hypomethylating agents and chemotherapy.
    Singh R; Fazal Z; Bikorimana E; Boyd RI; Yerby C; Tomlin M; Baldwin H; Shokry D; Corbet AK; Shahid K; Hattab A; Freemantle SJ; Spinella MJ
    Mol Oncol; 2022 Feb; 16(3):683-698. PubMed ID: 34482638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Refractory testicular germ cell tumors are highly sensitive to the second generation DNA methylation inhibitor guadecitabine.
    Albany C; Hever-Jardine MP; von Herrmann KM; Yim CY; Tam J; Warzecha JM; Shin L; Bock SE; Curran BS; Chaudhry AS; Kim F; Sandusky GE; Taverna P; Freemantle SJ; Christensen BC; Einhorn LH; Spinella MJ
    Oncotarget; 2017 Jan; 8(2):2949-2959. PubMed ID: 27936464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global DNA methylation in fetal human germ cells and germ cell tumours: association with differentiation and cisplatin resistance.
    Wermann H; Stoop H; Gillis AJ; Honecker F; van Gurp RJ; Ammerpohl O; Richter J; Oosterhuis JW; Bokemeyer C; Looijenga LH
    J Pathol; 2010 Aug; 221(4):433-42. PubMed ID: 20593487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant epigenetic inactivation of RASSF1A and MGMT gene and genetic mutations of KRAS, cKIT and BRAF in Indian testicular germ cell tumours.
    Ahmad F; Surve P; Natarajan S; Patil A; Pol S; Patole K; Das BR
    Cancer Genet; 2020 Feb; 241():42-50. PubMed ID: 31653608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Candidate DNA methylation drivers of acquired cisplatin resistance in ovarian cancer identified by methylome and expression profiling.
    Zeller C; Dai W; Steele NL; Siddiq A; Walley AJ; Wilhelm-Benartzi CS; Rizzo S; van der Zee A; Plumb JA; Brown R
    Oncogene; 2012 Oct; 31(42):4567-76. PubMed ID: 22249249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent epigenetic inactivation of the RASSF1A tumour suppressor gene in testicular tumours and distinct methylation profiles of seminoma and nonseminoma testicular germ cell tumours.
    Honorio S; Agathanggelou A; Wernert N; Rothe M; Maher ER; Latif F
    Oncogene; 2003 Jan; 22(3):461-6. PubMed ID: 12545168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erasure of methylation imprint at the promoter and CTCF-binding site upstream of H19 in human testicular germ cell tumors of adolescents indicate their fetal germ cell origin.
    Kawakami T; Zhang C; Okada Y; Okamoto K
    Oncogene; 2006 Jun; 25(23):3225-36. PubMed ID: 16434968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic profile of testicular germ cell tumours.
    Okamoto K; Kawakami T
    Int J Androl; 2007 Aug; 30(4):385-92; discussion 392. PubMed ID: 17521367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between
    Markulin D; Vojta A; Samaržija I; Gamulin M; Bečeheli I; Jukić I; Maglov Č; Zoldoš V; Fučić A
    Cancer Genomics Proteomics; 2017; 14(5):363-372. PubMed ID: 28871003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic silencing of the putative tumor suppressor gene testisin in testicular germ cell tumors.
    Kempkensteffen C; Christoph F; Weikert S; Krause H; Köllermann J; Schostak M; Miller K; Schrader M
    J Cancer Res Clin Oncol; 2006 Dec; 132(12):765-70. PubMed ID: 16810501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imprints and DPPA3 are bypassed during pluripotency- and differentiation-coupled methylation reprogramming in testicular germ cell tumors.
    Killian JK; Dorssers LC; Trabert B; Gillis AJ; Cook MB; Wang Y; Waterfall JJ; Stevenson H; Smith WI; Noyes N; Retnakumar P; Stoop JH; Oosterhuis JW; Meltzer PS; McGlynn KA; Looijenga LH
    Genome Res; 2016 Nov; 26(11):1490-1504. PubMed ID: 27803193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multipoint methylation analysis indicates a distinctive epigenetic phenotype among testicular germ cell tumors and testicular malignant lymphomas.
    Kawakami T; Okamoto K; Kataoka A; Koizumi S; Iwaki H; Sugihara H; Reeve AE; Ogawa O; Okada Y
    Genes Chromosomes Cancer; 2003 Sep; 38(1):97-101. PubMed ID: 12874790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic Remodeling through Downregulation of Polycomb Repressive Complex 2 Mediates Chemotherapy Resistance in Testicular Germ Cell Tumors.
    Singh R; Fazal Z; Corbet AK; Bikorimana E; Rodriguez JC; Khan EM; Shahid K; Freemantle SJ; Spinella MJ
    Cancers (Basel); 2019 Jun; 11(6):. PubMed ID: 31181810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High DNA methyltransferase 3B expression mediates 5-aza-deoxycytidine hypersensitivity in testicular germ cell tumors.
    Beyrouthy MJ; Garner KM; Hever MP; Freemantle SJ; Eastman A; Dmitrovsky E; Spinella MJ
    Cancer Res; 2009 Dec; 69(24):9360-6. PubMed ID: 19951990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoter methylation of DNA homologous recombination genes is predictive of the responsiveness to PARP inhibitor treatment in testicular germ cell tumors.
    Lobo J; Constâncio V; Guimarães-Teixeira C; Leite-Silva P; Miranda-Gonçalves V; Sequeira JP; Pistoni L; Guimarães R; Cantante M; Braga I; Maurício J; Looijenga LHJ; Henrique R; Jerónimo C
    Mol Oncol; 2021 Apr; 15(4):846-865. PubMed ID: 33513287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testis-expressed gene 11 inhibits cisplatin-induced DNA damage and contributes to chemoresistance in testicular germ cell tumor.
    Kitayama S; Ikeda K; Sato W; Takeshita H; Kawakami S; Inoue S; Horie K
    Sci Rep; 2022 Nov; 12(1):18423. PubMed ID: 36319719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of the DNA mismatch repair system in cisplatin sensitivity of testicular germ cell tumours.
    Rudolph C; Melau C; Nielsen JE; Vile Jensen K; Liu D; Pena-Diaz J; Rajpert-De Meyts E; Rasmussen LJ; Jørgensen A
    Cell Oncol (Dordr); 2017 Aug; 40(4):341-355. PubMed ID: 28536927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CpG island hypermethylation of cell-free circulating serum DNA in patients with testicular cancer.
    Ellinger J; Albers P; Perabo FG; Müller SC; von Ruecker A; Bastian PJ
    J Urol; 2009 Jul; 182(1):324-9. PubMed ID: 19447423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.